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Background and objectives: Accidental and intentional poisonings or drug overdoses constitute a
signiﬁcant source of aggregate morbidity, mortality, and health care expenditure. Studies evaluating
drug related hospitalization have estimated that approximately 5–10% of all hospital admissions
are drug related. The present study was carried out to investigate type, nature and incidence of drug
related admissions in our hospital settings.
Method: A hospital based retrospective study was conducted in 575 cases of drug related admis-
sions. The case records of patients admitted in various clinical departments of Amrita Institute
of Medical Sciences (AIMS) Hospital during last 8 years (January 2002–December 2009) were col-
lected and analyzed.
Results: During the retrospective study, the total number of drug related cases reported were 575.
Out of these, 35.5% cases were induced by central nervous system (CNS) drugs, 19.8% were by car-
diovascular system (CVS) drugs, 12.3% were by NSAIDs, 11.3% were by antibiotics and 9.9% were
by anticoagulants, 11.3% by other drugs which includes hormones, cytotoxic drugs, hypolipidem-
ics, etc. Four hundred and forty cases were admitted to emergency department. Common drug8202922482; mobile: +91
m (M. Sonal Sekhar).
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274 M. Sonal Sekhar et al.related problems resulting in hospital visits were due to intentional, accidental and overdose. The
incidence of drug related hospital admissions was found to be 0.20%.
Conclusion: The most of the accidental and suicidal cases were reported are by CNS drugs. Psy-
chiatric patients intentionally taking medicines as suicidal attempt and as a part of their illness. As
drug related problems are so signiﬁcant, increased awareness and enhanced collaborative efforts
among patients, physicians, pharmacists and caregivers within community and hospital have the
potential to minimize the impact of this problem.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Over the past 40 years, advances in drug therapies have both
improved patient care and led to an apparent increase in the
incidence of drug related problems being reported. Before
1960s, there were fewer drugs available and drug related prob-
lems were not systematically assessed. Literature from this
time focused on adverse drug reactions. Problems relating to
complications of drug therapy resulting in signiﬁcant illness
and hospital admission were ﬁrst highlighted in 1969 (Einar-
son, 1993; Winterstein et al., 2002). This early work was fol-
lowed by reports from other groups including the Boston
Collaborative Drug Surveillance program. These initial studies
put the frequency of such hospital admissions as 1.8–6.2%
(Hallas et al., 1993). The proportion of elderly emergency
admissions that were drug related hospital admissions
(DRHA) varied between 15% and 22% in Australian studies.
This is considerably higher than in studies that also included
younger patients (Chan et al., 2001). In Australia an incidence
of between 2.4% and 3.6% was found and in the United States
an incidence of between 3.1% and 6.2% was found. European
studies performed in medical departments admissions due to
certain ADRs according to WHO (World Health Organiza-
tion) criteria encounter 3.2% in France and 6.2% in Germany
of all admitted patients, while in a prospective computerized
event monitoring study in internal medicine departments in
Swiss general and teaching hospitals admissions were due to
ADRs encounter 3.3% (Fattinger et al., 2000; Pouyanne
et al., 2000). In a UK study of ADR related admissions in
all hospitals using the computer-assisted International Classiﬁ-
cation of Diseases (ICD) coding system ADR related admis-
sions represented 0.5% of total hospital admissions (Patel
et al., 2007). A study in India carried out in a tertiary referral
center in South India showed that admissions due to ADRs ac-
counted for 0.7% of total admissions and deaths due to ADRs
accounted for 1.8% of total ADRs (Ramesh et al., 2003).
When medications are prescribed for patients for the treat-
ment of disease, the full intent of all parties involved should be
the achievement of an optimal therapeutic outcome. Optimal
therapeutic outcome has been deﬁned as an absence of drug-
related problems (DRPs) (Roxburgh and Degenhardt, 2008;
Howard et al., 2008). A DRP is deﬁned as an event or circum-
stance that involves a patient’s drug treatment that actually, or
potentially, interferes with the achievement of an optimal out-
come (Easton et al., 2004; Hepler and Strand, 1990). Unre-
solved or unrecognized DRPs may manifest as drug-related
morbidity, which has been described as the phenomenon of
therapeutic malfunction or miscarriage the failure of a thera-
peutic agent to produce the intended outcome. If left un-
treated, drug-related morbidity may ultimately lead to drug-
related mortality. There is a considerable body of literaturethat suggests that a large proportion of drug-related morbidity
is preventable. The cost of drug-related morbidity and mortal-
ity in the ambulatory setting is considerable and should be
considered in health policy decisions with regard to pharma-
ceutical beneﬁts. On the basis of data obtained in the early
1990s, Johnson and Bootman (1995) estimated that, on aver-
age, $76.6 billion is spent annually in the ambulatory setting
in the United States to resolve DRPs, with drug-related hospi-
talizations being the largest component of this cost (Ernst and
Grizzle, 2001). Policies and services should be developed to
reduce and prevent drug-related morbidity and mortality
(Koh et al., 2003; Zargarzadeh et al., 2007). Purpose of the
study was to investigate type, nature and incidence of drug
related admissions in a tertiary care hospital in south India.2. Method
A retrospective study was conducted in the Medical Record
room of Amrita Institute of Medical Sciences and Research
Center Hospital (AIMS), Kochi. This is a 1200 bedded tertiary
care teaching hospital providing specialized healthcare services
to all strata of people in and around Kerala. The complete pro-
ject work was done according to the permission granted by the
ethical committee of AIMS Hospital and according to the per-
mission granted from Medical Records Department of AIMS
Hospital, Kochi. The case records of patients admitted in var-
ious clinical departments of AIMS Hospital during last 8 years
(January 2002–December 2009) were collected and analyzed.
All the patients admitted with drug related problems were in-
cluded in the study and the incomplete records were excluded.
Using a data collection form, information on the cases was ob-
tained. In addition to demographic variables like age and sex,
the factors of interest considered were diagnosis, drug involved
for reaction, drug class and nature of drug related problems,
etc. This retrospective data base of patients with drug related
admission to the hospital between the speciﬁed periods was
used to investigate the incidence of drug related problems. Per-
centage calculations, Microsoft word and Excel have been used
to generate tables, etc.
3. Result and discussion
The present study is aimed at evaluating the incidence of drug
related hospital admissions in a South Indian hospital. In addi-
tion to this the type of drugs associated with the hospitaliza-
tion are also reported. During our retrospective study, the
total number of drug related hospital admissions were found
to be 0.20%. A Meta analysis with 95 studies was reported,
a range of prevalence of medication-related hospitalizations
from 0.1% to 54% was found (Leendertse et al., 2010). These
Table 1 Number of drug related problems.
Sl. No. Class of drugs No. of drug
related cases
(N= 575)
%
1 Central nervous system drugs. 203 35.5
2 Cardiovascular drugs 114 19.8
3 NSAIDs 71 12.3
4 Antibiotics 65 11.3
5 Anticoagulant 57 09.9
6 Others (hormones, cytotoxic, oral
hypoglycemic drugs and drugs)
65 11.3
NSAIDs, non-steroidal anti-inﬂammatory drugs.
Table 2 CNS drugs vs. DRP cases.
CNS drugs Nature of DRP No. of cases Department
Phenytoin Overdose 89 Emergency
Phenobarbitone Overdose
Drug reaction
10
4
Emergency
Alprazolam Overdose 44 Emergency
Carbamazepene Overdose
Drug reaction
14
6
Emergency
Lorazepam Overdose 12 Emergency
Levodopa Drug reactions 8 Emergency
Triﬂuperazine Overdose 9 Emergency
Trihexylphenydyl Overdose 4 Emergency
Haloperidol Drug reactions 3 Emergency
Total DRP cases 203
CNS, central nerves system; DRP, drug related problem.
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ting, the studied population, the method of data collection and
the continent in which the study is performed. Combined stud-
ies in Europe show lower prevalence of medication-related
hospital admissions than in other continents included in the
study (Leendertse et al., 2010). A review of Australian studies
published were identiﬁed as 2.4–3.6% of which all the hospital
admissions were reported to be drug related (Roughead et al.,
1998).
While assessing the data it was conﬁrmed that most of the
drugs causing the drug induced hospitalizations were contrib-
uted by the CNS drugs (Table 1). Meta analysis of AustralianTable 3 CVS drugs vs. DRP cases.
CVS drugs Nature of DRP
Beta-blockers Overdose
Drug reactions
ACE inhibitors Drug reactions
Diuretics Drug reactions
Nitrates Drug reactions
Angiotensin-II receptor blockers Drug reaction
Digoxin Overdose
Amiodarone Drug reactions
Calcium channel Blocker Overdose
Total DRP cases
CVS, cardio vascular system; DRP, drug related problem; ACE, angiotestudies published from 1988 to 1996 reported that themost com-
monly implicated drug groups were cytotoxics, cardiovascular
agents, anticoagulants and nonsteroidal anti inﬂammatory
drugs (Roughead, 1999). In another study, antithrombotics
showed the highest incidence (0.24%) of drug related admis-
sions (Schneeweiss et al., 2001).
Medications that act on the central nervous system (35.5%)
were most often related to a trauma. In our study over dose
toxicity is the common reason for emergency admissions due
to CNS drugs. In a similar study that was reported CNS drugs
contributed for 5.1% of cases (Leendertse et al., 2008). In an-
other study, CNS drugs most commonly involved were drugs
of abuse (23.2%) and anticonvulsants (17.1%) (Prince et al.,
1992) (Table 2).
CVS drugs were the second contributing category drugs for
drug related hospitalizations. The major drugs of this category
were presented in Table 3. Among these drugs thiazide diuret-
ics were identiﬁed as contributors of hyponatremia were as
antiarrhythmics contributed to toxicities. Almost similar result
was found in another study where CVS drugs contributed to
18.3% of the emergency visits (Patel and Zed, 2002). Dartnell
et al. found that 5.7% of emergency admissions to hospital
over a period of 1 month were drug-related, with 83 drugs
being implicated. Over 30% of these medications included
antihypertensives, diuretics, anticoagulants and other cardio-
vascular drugs (Miller et al., 2001).
In our study 12.3% of drug related hospitalizations cases
were due to NSAIDs. A UK study estimated that 1.9% of
NSAID users were admitted to hospital each year with upper
gastrointestinal emergencies (Blower et al., 1997). There are
clear differences in risk with different NSAIDs, and some
clearly are associated with higher risks of upper gastrointesti-
nal bleeding than others. In this study, we have found that
Aspirin is the main reason for hospital admission in 69% of
cases among NSAID users. While the Italian study demon-
strated a particularly high risk with ketorolac (Garcia Rodri-
guez et al., 1998). A new study reveals that NSAIDs such as
Ibuprofen increases the risk of a hospital admission for the
condition by 30% (Table 4).
Antibiotics were also found to have a signiﬁcant contribu-
tion to the category of drug related admissions (11.3%). Drugs
included were sulfasalazine, amino glycosides, antileprotics,
antitubercular and tetracyclines. Aminoglycoside induced tox-
icities were mostly ototoxicities mainly caused by streptomyc-
ins. Antileprotics–dapsone induced methaemoglobinaemia and
ATT–rifampicin induced hepatitis, drug reactions were alsoNo. of cases Department
7
22
Emergency
20 Cardiology
20 Internal medicine
6 Internal medicine
7 Internal medicine
15 Emergency
14 Internal medicine
3 Internal medicine
114
nsin converting enzyme.
Table 4 NSAIDs drugs vs. DRP cases.
NSAIDs Nature of DRP No. of cases Department
Aspirin Drug reactions 49 Emergency
Celecoxib Overdose
Drug reactions
8
4
Internal medicine
Indomethacin Drug reactions 6 Internal medicine
Nimesulide Drug reactions 4 Internal medicine
Total DRP cases 71
NSAIDs, non steroidal anti inﬂammatory drugs; DRP, drug related problem.
Table 5 Antibiotics vs. DRP cases.
Antibiotics Nature of DRP No. of cases Department
Aminoglycosides Overdose
Drug reaction
2
22
Internal medicine
Sulfonamides Overdose
Drug reaction
3
9
Internal medicine
Antituberculars Drug reaction 13 Pulmonary medicine
Antileprotics Drug reaction 10 Dermatology
Tetracyclines Drug reaction 6 Internal medicine
Total DRP 65
DRP, drug related problem.
Table 6 Anticoagulants Vs. DRP cases.
Anticoagulants Nature of DRP cases No. of DRP cases Department
Aspirin Overdose 27 Emergency
Warfarin Overdose 18 Emergency
Clopidogrel Drug reactions 12 Emergency
Total DRP 57
DRP, drug related problem.
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review of drug related visits to hospital emergency departments
over a period of one year in US. This antibiotic contributes for
15.4% of the cases (Patel and Zed, 2002) (Table 5).
In our study anticoagulants were responsible for 9.9% of
cases of drug related hospital admissions. These were due to
acute gum bleedings, upper gastrointestinal bleedings and
allergic reactions caused by these drugs. Various studies had
shown antithrombotics had highest incidence of hospitaliza-
tion (Schneeweiss et al., 2001). In a Netherland study, medica-
tion associated with potentially preventable hospital
admissions were those that affect blood coagulation, such asTable 7 Other Drugs vs. DRP cases.
Other drugs Nature of DRP
Cytotoxic drugs Overdose
Drug reaction
Oral hypoglycemics Overdose
Hypolipidemics Overdose
Antihistamines Drug reaction
Total DRP
DRP, drug related problem.antiplatelet drugs (8.7%), oral anticoagulants (6.3%), NSAIDs
(5.1%), and a combination of these medicines (10.5%) (Leend-
ertse et al., 2008) (Table 6).
Other classes of drugs such as cytotoxic drugs, hypolipidem-
ic, antihistamines, and oral hypoglycemic agents were remark-
ably causing drug related hospitalizations (Table 7). Steroid
induced cases were cushing syndrome,myopathies and hypogly-
cemia caused by drugs like prednisone and betamethasone.
The antidotes given below were found to be prescribed in
corresponding over dose cases. Sometimes it may be given as
discharge medications or as the course of medication during
the hospital stay (Table 8).No. of cases Department
11
21
Internal medicine
14 Internal medicine
12 Internal medicine
7 Emergency
65
Table 8 Drugs vs. Antidotes.
Drugs Antidotes
Benzodiazepenes Flumazanil
Antipsychotics
(extrapyramidal reactions)
Diphenhydramine hydrochloride
+ benzetropine mesylate
Opiods Nalozone hydrochloride
Lorazepam Flumazanil
Beta-blockers Theophylline
Digoxin Digoxin Immune Fab
Calcium channel blockers Glucagon/insulin
Warfarin Phytome-a-dione (Vitamin-K)
Isoniazid Pyridoxine
Aspirin Activated charcoal
Metformin Octreotide
Carbamazepene Activated charcoal
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A broad and comprehensive deﬁnition of drug related admis-
sions indicates that these are signiﬁcant problems within the
health system, with up to 0.20% of admissions to hospital
being drug related. The most frequently implicated drug clas-
ses are drugs acting on central nervous system, cardiovascular
drugs, antibiotics and NSAIDs.
This study highlights the need for a greater awareness for
drug related admissions. The solution to this problem is en-
hanced collaborative efforts among patients, physicians, phar-
macists and caregivers within the community and the hospital.
Recognition of patient, prescriber, drug and disease factors as
well as appropriate therapeutic modiﬁcation, should be pur-
sued. This can be enhanced by a research focus on current
studies that identify preventable events accurately, to explore
how they happen and how to prevent them.
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